UAB is leading the way in research for an intranasal vaccine against COVID-19 which they say could be beneficial for many reasons.
Altimmune and UAB intranasal Covid-19 vaccine posts more encouraging results
bizjournals.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bizjournals.com Daily Mail and Mail on Sunday newspapers.
Intranasal COVID-19 vaccine candidate preclinically tested at UAB expected to start clinical trial
news-medical.net - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from news-medical.net Daily Mail and Mail on Sunday newspapers.
COVID-19 vaccine candidate, tested at UAB, will start Phase 1 clinical trial UAB and Altimmune collaborate on COVID-19 vaccine trial (Source: UAB) By WBRC Staff | February 19, 2021 at 3:24 PM CST - Updated February 19 at 3:24 PM
BIRMINGHAM, Ala. (WBRC) - A big update in the COVID-19 vaccine testing at the University of Alabama at Birmingham. The Altimmune Inc. vaccine candidate that was tested at UAB in 2020 is expected to start patient enrollment for its Phase 1 clinical trial next week.
Altimmune announced the United States Food and Drug Administration has cleared the company’s Investigational New Drug application for its Phase 1 clinical trial of AdCOVID.